Known targets — ChEMBL curated mechanism
ADRA1AADRA1BADRA1DADRB1ADRB2ADRB3CYP11B1DPP4FGFR1FGFR2FGFR3FGFR4HRH1JAK1JAK2JAK3KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITNAOPRD1OPRK1OPRM1PPDGFRBPIK3CDSCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASMOTYK2polrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Phosphoric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDR known ✓ | P35968 | 1/20 | 0.37 |
| ▸ | DPP4 known ✓ | P27487 | 1/20 | 0.35 |
| ▸ | MGMT | P16455 | 6/20 | 0.44 |
| ▸ | CDK1 | P06493 | 5/20 | 0.44 |
| ▸ | CCNB1 | P14635 | 5/20 | 0.44 |
| ▸ | CCNA2 | P20248 | 5/20 | 0.44 |
| ▸ | CDK2 | P24941 | 5/20 | 0.44 |
| ▸ | CCNA1 | P78396 | 5/20 | 0.44 |
| ▸ | PDPK1 | O15530 | 1/20 | 0.43 |
| ▸ | GDA | Q9Y2T3 | 1/20 | 0.43 |
| ▸ | POLA1 | P09884 | 1/20 | 0.39 |
| ▸ | AURKB | Q96GD4 | 1/20 | 0.37 |
| ▸ | PI4KA | P42356 | 2/20 | 0.35 |
| ▸ | PI4K2B | Q8TCG2 | 2/20 | 0.35 |
| ▸ | PI4K2A | Q9BTU6 | 2/20 | 0.35 |
| ▸ | PI4KB | Q9UBF8 | 2/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | DRD3 | P35462 | 1/20 | 0.35 |
| ▸ | XDH | P47989 | 1/20 | 0.35 |
| ▸ | LRRK2 | Q5S007 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29677204 | 0.94 | CDK2 (0.49) | MGMTCDK1CCNB1CCNA2CDK2 | |
| SCHEMBL136630 | 0.94 | CDK2 (0.49) | MGMTCDK1CCNB1CCNA2CDK2 | |
| SCHEMBL25228360 | 0.89 | MGMT (0.43) | MGMTCDK1CCNB1CCNA2CDK2 | |
| SCHEMBL717431 | 0.82 | CA5A (0.39) | MGMTCDK1CCNB1CCNA2CDK2 | |
| SCHEMBL1024249 | 0.81 | ADORA1 (0.35) | MGMTCDK1CCNB1CCNA2CDK2 | |
| SCHEMBL30416185 | 0.80 | PDPK1 (0.49) | MGMTCDK1CCNB1CCNA2CDK2 | |
| Ribose (Furanose) SCHEMBL17275115 | 0.80 | MGMT (0.38) | MGMTCDK1CCNB1CCNA2CDK2 | |
| SCHEMBL15167310 | 0.79 | TRPM2 (0.41) | — | |
| SCHEMBL9656473 | 0.78 | PDPK1 (0.46) | MGMTCDK1CCNB1CCNA2CDK2 | |
| SCHEMBL15166956 | 0.78 | TRPM2 (0.43) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 55 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10676752-B2 | Methods controlling gene expression | BASF PLANT SCIENCE COMPANY GMBH (DE) | 2020-06-09 | — | — | US | disclosed |
| US-9708619-B2 | Methods for controlling gene expression using ta-siRNA | BASF PLANT SCIENCE GMBH (DE) | 2017-07-18 | — | — | US | disclosed |
| US-20160152994-A1 | METHODS CONTROLLING GENE EXPRESSION | BASF PLANT SCIENCE GMBH (DE) | 2016-06-02 | — | — | US | disclosed |
| EP-2980220-A1 | IMPROVED METHODS CONTROLLING GENE EXPRESSION | BASF Plant Science GmbH (DE) | 2016-02-03 | — | — | EP | disclosed |
| US-20150368663-A1 | METHOD FOR ISOLATION OF TRANSCRIPTION TERMINATION SEQUENCES | BASF PLANT SCIENCE GMBH (DE) | 2015-12-24 | — | — | US | disclosed |
| US-9133466-B2 | Method for isolation of transcription termination sequences | BASF PLANT SCIENCE GMBH (DE) | 2015-09-15 | — | — | US | disclosed |
| US-9085774-B2 | Methods controlling gene expression | BASF PLANT SCIENCE GMBH (DE) | 2015-07-21 | — | — | US | disclosed |
| US-20140237683-A1 | EXPRESSION ENHANCING INTRON SEQUENCES | BASF PLANT SCIENCE GMBH (DE) | 2014-08-21 | — | — | US | disclosed |
| US-8759506-B2 | Expression enhancing intron sequences | BASF PLANT SCIENCE GMBH (DE) | 2014-06-24 | — | — | US | disclosed |
| EP-1874936-B1 | IMPROVED METHODS CONTROLLING GENE EXPRESSION | BASF PLANT SCIENCE GMBH (DE) | 2013-10-30 | — | — | EP | disclosed |
| EP-1781784-A2 | METHOD FOR ISOLATION OF TRANSCRIPTION TERMINATION SEQUENCES | BASF Plant Science GmbH (DE) | 2007-05-09 | — | — | EP | disclosed |
| WO-2007039454-A1 | METHODS FOR CONTROLLING GENE EXPRESSION USING TA-SIRAN | BASF PLANT SCIENCE GMBH (DE) | 2007-04-12 | — | — | WO | disclosed |
| EP-1723241-A1 | TRANSGENIC EXPRESSION CONSTRUCTS FOR VEGETATIVE PLANT TISSUE SPECIFIC EXPRESSION OF NUCLEIC ACIDS | BASF Plant Science GmbH (DE) | 2006-11-22 | — | — | EP | disclosed |
| WO-2006111512-A1 | IMPROVED METHODS CONTROLLING GENE EXPRESSION | BASF PLANT SCIENCE GMBH (DE) | 2006-10-26 | — | — | WO | disclosed |
| WO-2006094976-A2 | EXPRESSION ENHANCING INTRON SEQUENCES | BASF PLANT SCIENCE GMBH (DE) | 2006-09-14 | — | — | WO | disclosed |
| EP-1629096-A1 | METHODS FOR ASSEMBLING MULTIPLE EXPRESSION CONSTRUCTS | BASF Plant Science GmbH (DE) | 2006-03-01 | — | — | EP | disclosed |
| WO-2006013072-A2 | METHOD FOR ISOLATION OF TRANSCRIPTION TERMINATION SEQUENCES | BASF PLANT SCIENCE GMBH (DE) | 2006-02-09 | — | — | WO | disclosed |
| WO-2005108568-A1 | METHODS FOR ASSEMBLING MULTIPLE EXPRESSION CONSTRUCTS | BASF PLANT SCIENCE GMBH (DE) | 2005-11-17 | — | — | WO | disclosed |
| WO-2005085450-A1 | TRANSGENIC EXPRESSION CONSTRUCTS FOR VEGETATIVE PLANT TISSUE SPECIFIC EXPRESSION OF NUCLEIC ACIDS | BASF PLANT SCIENCE GMBH (DE) | 2005-09-15 | — | — | WO | disclosed |
| WO-2002034924-A2 | EXPRESSION CASSETTE USED FOR THE TRANSGENIC EXPRESSION OF NUCLEIC ACIDS IN THE EMBRYONIC EPIDERMIS AND/OR FLOWER OF PLANTS | BASF PLANT SCIENCE GMBH (DE) | 2002-05-02 | — | — | WO | disclosed |